PTDSS1 expression was reported positively correlated with tumor-associated macrophage (TAM) abundance, while negatively associated with the overall survival of breast carcinoma patients, suggesting PTDSS1 might be developed as a potential therapeutic target to modify tumor-promoting inflammation in breast cancer [20]. Here, PTDSS1 is linked to breast carcinoma.